Oriana A. Perez
Affiliations: | Immunology | University of Connecticut Health Center, Farmington, CT, United States |
Google:
"Oriana Perez"Parents
Sign in to add mentorKamal M Khanna | grad student | UConn Health | |
Boris Reizis | post-doc | New York University (Microtree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sulczewski FB, Maqueda-Alfaro RA, Alcántara-Hernández M, et al. (2023) Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses. Nature Immunology |
Yun TJ, Igarashi S, Zhao H, et al. (2021) Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells. Science Immunology. 6 |
Hartl J, Serpas L, Wang Y, et al. (2021) Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. The Journal of Experimental Medicine. 218 |
Soni C, Perez OA, Voss WN, et al. (2020) Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA. Immunity |
Ural BB, Yeung ST, Damani-Yokota P, et al. (2020) Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties. Science Immunology. 5 |
Leylek R, Alcántara-Hernández M, Lanzar Z, et al. (2019) Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Reports. 29: 3736-3750.e8 |
Lau CM, Tiniakou I, Perez OA, et al. (2018) Transcription factor Etv6 regulates functional differentiation of cross-presenting classical dendritic cells. The Journal of Experimental Medicine |
Perez OA, Yeung ST, Vera-Licona P, et al. (2017) CD169(+) macrophages orchestrate innate immune responses by regulating bacterial localization in the spleen. Science Immunology. 2 |
Qiu Z, Huang H, Grenier JM, et al. (2015) Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma. Cancer Immunology Research. 3: 536-46 |